The small intestine as a xenobiotic-metabolizing organ.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Drug Metabolism And Disposition

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/DMD.31.12.1520PMID 14625348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interspecies variations in small intestinal and hepatic drug hydroxylation and glucuronidation.

  2009cited by this paper
• CYTOCHROME P-450 3 A 4 : Regulation and Role in Drug Metabolism

  2005cited by this paper
• Phenobarbital inducible drug monooxygenase activity in the small intestine of mice

  2004cited by this paper
• The metabolism of 7,12-dimethylbenz (a) anthracene by homogenates of the stomach and small intestine of mice

  2004cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Characterization of mouse small intestinal cytochrome P450 expression.

  2003cited by this paper
• Regulation of cyp3a gene transcription by the pregnane x receptor.

  2002cited by this paper
• Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals.

  2002cited by this paper
• Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

  2002cited by this paper
• Differential expression of glutathione S-transferase isoenzymes in murine small intestine and colon.

  2002cited by this paper
• The Mucosa of the Small Intestine

  2002cited by this paper
• Cytochromes P450 and metabolism of xenobiotics

  2001cited by this paper
• The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†

  2001cited by this paper
• Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1).

  2001influential reference
• Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.

  2001cited by this paper
• Metabolic characterization of the major human small intestinal cytochrome p450s.

  2001cited by this paper
• cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine.

  2001cited by this paper
• The effects of grapefruit juice on the pharmacokinetics of erythromycin

  2001cited by this paper
• Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.

  2000cited by this paper
• Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.

  2000cited by this paper
• CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.

  2000cited by this paper
• Use of everted sacs of mouse small intestine as enzyme sources for the study of drug oxidation activities in vitro

  2000cited by this paper
• Sulfotransferases: genetics and role in toxicology.

  2000cited by this paper
• Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.

  2000cited by this paper
• Genetic mosaic analysis based on Cre recombinase and navigated laser capture microdissection.

  2000cited by this paper
• Quantitative and qualitative gender-related differences in jejunal glutathione S-transferase in the rat effect of testosterone administration.

  2000cited by this paper
• Induction of mouse CYP2J by pyrazole in the eye, kidney, liver, lung, olfactory mucosa, and small intestine, but not in the heart.

  2000cited by this paper
• Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.

  2000cited by this paper
• Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes

  2000cited by this paper
• Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract.

  2000cited by this paper
• Polymorphic Gene Regulation and Interindividual Variation of UDP-glucuronosyltransferase Activity in Human Small Intestine*

  2000cited by this paper
• P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues.

  1999cited by this paper
• Comparison of CYP2D6 Content and Metoprolol Oxidation Between Microsomes Isolated from Human Livers and Small Intestines

  1999cited by this paper
• Induction of rat small intestinal cytochrome P-450 2J4.

  1999influential reference
• The mutagenicity of benzo[a]pyrene in mouse small intestine.

  1999cited by this paper
• Differential expression of

  1999cited by this paper
• Cytochrome P-450 3A4: regulation and role in drug metabolism.

  1999cited by this paper
• Glutathione S‐Transferases in Small Intestinal Mucosa of Patients with Coeliac Disease

  1999cited by this paper
• Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.

  1999cited by this paper
• A novel cytochrome P450 3A isoenzyme in rat intestinal microsomes.

  1999cited by this paper
• Induction of phase II biotransformation reactions in rat jejunum during lactation. Possible involvement of prolactin.

  1999cited by this paper
• Malnutrition sequela on the drug metabolizing enzymes in male Holtzman rats.

  1999cited by this paper
• Cloning and characterization of a mammalian N-acetylglucosamine-6-sulfotransferase that is highly restricted to intestinal tissue.

  1999cited by this paper
• Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole.

  1999cited by this paper
• Is the role of the small intestine in first-pass metabolism overemphasized?

  1999cited by this paper
• Characterization of human small intestinal cytochromes P-450.

  1999influential reference
• Molecular Cloning, Expression, and Characterization of Novel Human SULT1C Sulfotransferases That Catalyze the Sulfonation ofN-Hydroxy-2-acetylaminofluorene*

  1998cited by this paper
• UDP-glucuronosyltransferase UGT1A7 induced in rat small intestinal mucosa by oral administration of 2-naphthoflavone.

  1998cited by this paper
• Comparison of human liver and small intestinal glutathione S-transferase-catalyzed busulfan conjugation in vitro.

  1998cited by this paper
• Drug Interactions with Grapefruit Juice

  1998cited by this paper
• Age-related changes in antioxidant enzyme activities in the small intestine and liver from Wistar rats.

  1998cited by this paper
• Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels.

  1998cited by this paper
• Characterization of the cytochrome P450 CYP2J4: expression in rat small intestine and role in retinoic acid biotransformation from retinal.

  1998cited by this paper
• Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.

  1998cited by this paper
• Effect of 26,26,26,27,27,27-Hexafluoro-1,25-Dihydroxyvitamin D3on the Expression of Vitamin-D-Responsive Genes in Vitamin-D-Deficient Mice

  1998cited by this paper
• Effects of the sulforaphane analog compound 30, indole-3-carbinol, D-limonene or relafen on glutathione S-transferases and glutathione peroxidase of the rat digestive tract.

  1998cited by this paper
• Drug Interactions with Grapefruit Juice

  1997cited by this paper
• Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

  1997cited by this paper
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

  1997cited by this paper
• REGULATION OF CYTOCHROME P 4501 A 1 EXPRESSION IN RAT SMALL INTESTINE

  1997cited by this paper
• Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

  1997cited by this paper
• Regulation of cytochrome P4501A1 expression in rat small intestine.

  1997cited by this paper
• Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver.

  1997cited by this paper
• CDNA cloning, heterologous expression, and characterization of rat intestinal CYP2J4.

  1997cited by this paper
• CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance.

  1997cited by this paper
• The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies.

  1997cited by this paper
• Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression.

  1996cited by this paper
• Human Phenol Sulfotransferase Gene Contains Two Alternative Promoters: Structure and Expression of the Gene

  1996cited by this paper
• Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.

  1996cited by this paper
• First‐pass metabolism of midazolam by the human intestine

  1996cited by this paper
• Purification, characterization and tissue distribution of human class theta glutathione s‐transferase T1‐1

  1996cited by this paper
• Characterization of rat small intestinal cytochrome P450 composition and inducibility.

  1996influential reference
• Cloning and characterization of the

  1996cited by this paper
• Inhibitory effect of dietary 4-ipomeanol on DNA adduct formation by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in male CDF1 mice.

  1995cited by this paper
• Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family

  1995cited by this paper
• Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues.

  1995cited by this paper
• Hepa-1 enzyme induction assay as an in vitro indicator of the CYP1A1-inducing potencies of laboratory rodent diets in vivo.

  1994cited by this paper
• Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less.

  1994cited by this paper
• Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

  1994cited by this paper
• Induction of rat hepatic and intestinal glutathione s-transferases and glutathione by dietary naturally-occurring anticarcinogens.

  1993cited by this paper
• Rat small intestinal cytochromes P450 probed by warfarin metabolism.

  1993cited by this paper
• Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures.

  1992cited by this paper
• Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.

  1992cited by this paper
• Pathology of the Gastrointestinal Tract

  1992cited by this paper
• Dietary modulation of cytochrome P450 in the small intestinal epithelium.

  1991cited by this paper
• Small intestinal cytochromes P450.

  1991influential reference
• Biotransformation enzymes in human intestine: critical low levels in the colon?

  1991cited by this paper
• Interaction of citrus juices with felodipine and nifedipine.

  1991cited by this paper
• P450IIB gene expression in rat small intestine: cloning of intestinal P450IIB1 mRNA using the polymerase chain reaction and transcriptional regulation of induction.

  1990cited by this paper
• Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

  1990cited by this paper
• Immunohistochemical localization of ethanol-inducible P450IIE1 in the rat alimentary tract.

  1990cited by this paper
• Cytochromes P-450 in the intestinal mucosa of man.

  1989cited by this paper
• Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine--II. Conjugases.

  1988cited by this paper
• Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

  1987cited by this paper
• Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase.

  1987cited by this paper
• Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.

  1985cited by this paper
• The morphology of the gastrointestinal tract.

  1977cited by this paper
• A comparative study of xenobiotic-metabolizing enzymes in liver and intestine of various animal species.

  1974influential reference
• Aryl hydrocarbon (benzo ( ) pyrene) hydroxylase: inducible in extrahepatic tissues of mouse strains not inducible in liver.

  1973cited by this paper

• Effect of Prolonged-acting Insulin on Intestinal and Hepatic Metabolism of 4-nitrophenol in STZ-Induced Experimental Diabetes

  2025cites this paper
• Human Small Intestinal Tissue Models to Assess Barrier Permeability: Comparative Analysis of Caco-2 Cells, Jejunal and Duodenal Enteroid-Derived Cells, and EpiIntestinalTM Tissues in Membrane-Based Cultures with and Without Flow

  2025cites this paper
• Development of Sheep Duodenum Intestinal Organoids and Implementation of High-Throughput Screening Platform for Veterinary Applications

  2025cites this paper
• Drug Metabolism Mechanisms And Pharmacokinetics Strategies In Implications For Drug Design: A Comprehensive Review

  2024cites this paper
• Experimental and computational models to investigate intestinal drug permeability and metabolism

  2023cites this paper
• Special Section on Perspective on Drug Metabolism and Disposition, Part I — Minireview Fifty Years of Aryl Hydrocarbon Receptor Research as Reflected in the Pages of Drug Metabolism and Disposition

  2023cites this paper
• Fifty Years of Aryl Hydrocarbon Receptor Research as Reflected in the Pages of Drug Metabolism and Disposition

  2023cites this paper
• Gut-on-a-chip models for dissecting the gut microbiology and physiology

  2023cites this paper
• Impact of Various High Fat Diets on Gene Expression and the Microbiome Across the Mouse Intestines

  2023influential citation
• Studyon theAbsorptionofArsenic Species inRealgarBased on the Form and Valence

  2022cites this paper
• Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment

  2022cites this paper
• Investigation of Intestinal Absorption and Excretion of Paracetamol in Streptozotocin-Induced Hyperglycemia

  2022cites this paper
• Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics

  2022cites this paper
• Deletion of Constitutive Androstane Receptor Led to Intestinal Alterations and Increased Imidacloprid in Murine Liver

  2022cites this paper
• Formation of CYP3A‐specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β‐hydroxycholesterol/cholesterol ratio

  2022cites this paper
• Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer

  2022cites this paper
• Study on the Absorption of Arsenic Species in Realgar Based on the Form and Valence

  2022cites this paper
• The interaction between tea polyphenols and host intestinal microorganisms: an effective way to prevent psychiatric disorders.

  2021cites this paper
• An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes

  2021cites this paper
• Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

  2021cites this paper
• Effects of Shengmai San on key enzymes involved in hepatic and intestinal drug metabolism in rats.

  2021cites this paper
• UPLC-MS/MS analysis of the Michaelis-Menten kinetics of CYP3A-mediated midazolam 1'- and 4-hydroxylation in rat brain microsomes.

  2021cites this paper
• Assessing donor-to-donor variability in human intestinal organoid cultures

  2021influential citation
• Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor.

  2021cites this paper
• Identifying candidate detoxification genes in the ecdysteroid kinase-like (EcKL) and cytochrome P450 gene families in Drosophila melanogaster by integrating evolutionary and transcriptomic data

  2020cites this paper
• Presence or absence of microbiome modulates the response of mice organism to administered drug nabumetone.

  2020cites this paper
• Development and characterization of rat duodenal organoids for ADME and toxicology applications.

  2020cites this paper
• Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis

  2020cites this paper
• Regional distributions of UDP-glucuronosyltransferase activities toward estradiol and serotonin in the liver and small intestine of cynomolgus macaques.

  2020cites this paper
• Gellan Gum Promotes the Differentiation of Enterocytes from Human Induced Pluripotent Stem Cells

  2020cites this paper
• Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.

  2020cites this paper
• Comparable Intestinal and Hepatic First-Pass Effect of YL-IPA08 on the Bioavailability and Effective Brain Exposure, a Rapid Anti-PTSD and Anti-Depression Compound

  2020cites this paper
• Metabolomic analysis reveals the mechanism of aluminum cytotoxicity in HT-29 cells

  2019cites this paper
• Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine

  2019cites this paper
• Insulin resistance accelerated the clearance of resveratrol: A note of caution

  2019cites this paper
• Contributions of Hepatic and Intestinal Metabolism to the Disposition of Niclosamide, a Repurposed Drug with Poor Bioavailability

  2019cites this paper
• Egg White Hydrolysate as a functional food ingredient to prevent cognitive dysfunction in rats following long-term exposure to aluminum

  2019cites this paper
• Evaluation of human primary intestinal monolayers for drug metabolizing capabilities

  2019cites this paper
• Current trends in drug metabolism and pharmacokinetics

  2019cites this paper
• Role of intestinal microecology in the regulation of energy metabolism by dietary polyphenols and their metabolites

  2019cites this paper
• Isolating Rat Intestinal Explants for In Vitro Cultures

  2019influential citation
• Drug Metabolism and Pharmacogenetics

  2019cites this paper
• A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum

  2019cites this paper
• Gut remediation: a new approach to reduce the accumulation of heavy metals by using probiotics

  2019cites this paper
• Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model

  2019cites this paper
• Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer

  2018cites this paper
• Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and Enterotoxicity

  2018cites this paper
• Extrahepatic cytochrome P450s play an insignificant role in triptolide-induced toxicity

  2018influential citation
• Interplay between elemental imbalance-related PI3K/Akt/mTOR-regulated apoptosis and autophagy in arsenic (III)-induced jejunum toxicity of chicken

  2018cites this paper
• The aryl hydrocarbon receptor and retinoid receptors cross-talk at the CYP1A1 promoter in vitro

  2018cites this paper
• Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species

  2018cites this paper
• Vitamin D deficiency in the ApcPirc/+ rat does not exacerbate colonic tumorigenesis, while low dietary calcium might be protective

  2018cites this paper
• Thymol in the intestinal tract of broiler chickens after sustained administration of thyme essential oil in feed

  2018cites this paper
• Physiologically Based Oral Absorption Modelling to Study Gut-Level Drug Interactions.

  2018cites this paper
• Special Section – New Models in Drug Metabolism and Transport Cryopreserved Human Intestinal Mucosal Epithelium : A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism , Cytochrome P 450 Induction , and Enterotoxicity

  2018cites this paper
• Chronic treatment with fluoride affects the jejunum: insights from proteomics and enteric innervation analysis

  2018cites this paper
• 1.05 – Oral Exposure and Absorption of Toxicants☆

  2018cites this paper
• Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics.

  2018cites this paper
• Induction of drug metabolism along the rat intestinal tract

  2018influential citation
• Falcarinol Is a Potent Inducer of Heme Oxygenase-1 and Was More Effective than Sulforaphane in Attenuating Intestinal Inflammation at Diet-Achievable Doses

  2018cites this paper
• Induction of phase I and II drug metabolism in rat small intestine and colon in vitro

  2018cites this paper
• Chapter 1 Introduction EG van de Kerkhof IAM de Graaf GMM Groothuis

  2017influential citation
• Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds.

  2017cites this paper
• Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four Donors

  2017cites this paper
• Molecular and cellular studies on the absorption, function, and safety of food components in intestinal epithelial cells

  2017cites this paper
• Models for drug absorption from the small intestine: where are we and where are we going?

  2017cites this paper
• Prédiction in silico de l'absorption intestinale et de la pénétration cérébrale des pesticides chez l'homme

  2017cites this paper
• iTRAQ-based proteomic technology revealed protein perturbations in intestinal mucosa from manganese exposure in rat models

  2017cites this paper
• Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers

  2017cites this paper
• Identification of the principal transcriptional regulators for low-fat and high-fat meal responsive genes in small intestine

  2017cites this paper
• Nature et conséquences des interactions entre transporteurs membranaires et pesticides

  2017cites this paper
• Mechanistic Toxicity Assessment of Hexahydroisohumulone in Canine Hepatocytes, Renal Proximal Tubules, Bone Marrow-Derived Mesenchymal Stem Cells, and Enterocyte-like Cells

  2016cites this paper
• Modulation of Murine Intestinal Gene Expression byDietary Fat: Spatial Variation and Saturation Effect

  2016cites this paper
• Pathway underlying small intestine apoptosis by dietary nickel chloride in broiler chickens.

  2016cites this paper
• The effect of vitamin D on gene expression in colorectal tumours and normal colon.

  2016cites this paper
• Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models

  2016cites this paper
• ASSESSMENT OF POLYCYCLIC AROMATIC HYDROCARBON BIOAVAILABILITY FROM SOIL USING THE JUVENILE SWINE MODEL

  2016cites this paper
• Acyl-glucuronide as a Possible Cause of Trovafloxacin-Induced Liver Toxicity: Induction of Chemokine (C-X-C Motif) Ligand 2 by Trovafloxacin Acyl-glucuronide.

  2016cites this paper
• Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier.

  2016cites this paper
• Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status

  2016cites this paper
• An update on the role of intestinal cytochrome P450 enzymes in drug disposition

  2016cites this paper
• Comprehensive characterization of the in vitro and in vivo metabolites of ziyuglycoside I in rat microsome, intestinal flora, excretion specimen and fresh tissues based on LC-Q-TOF/MS.

  2016cites this paper
• Why oral opioids may not be effective in a subset of chronic pain patients

  2016cites this paper
• Do biomarkers of exposure and effect correlate with internal exposure to PAHs in swine?

  2016cites this paper
• Population pharmacokinetics, optimised design and sample size determination for rifampicin, isoniazid, ethambutol and pyrazinamide in the mouse.

  2016cites this paper
• Explication of Definitional Description and Empirical Use of Fraction of Orally Administered Drugs Absorbed From the Intestine (Fa) and Intestinal Availability (Fg): Effect of P-glycoprotein and CYP3A on Fa and Fg.

  2016cites this paper
• Gut: An underestimated target organ for Aluminum.

  2016cites this paper
• Comparing the metabolism of quercetin in rats, mice and gerbils

  2016cites this paper
• Evaluation of the synergistic effect of Allium sativum, Eugenia jambolana, Momordica charantia, Ocimum sanctum, and Psidium guajava on hepatic and intestinal drug metabolizing enzymes in rats

  2016cites this paper
• Nonlinear transcriptomic response to dietary fat intake in the small intestine of C57BL/6J mice

  2016cites this paper
• PREDICTING PHARMACOKINETIC BEHAVIOR AND DOSE OF SILDENAFIL AND VORICONAZOLE IN NEONATAL AND PEDIATRIC POPULATIONS BY IN VITRO METABOLISM AND PBPK MODELING

  2015cites this paper
• 13C stable isotope labeling followed by ultra-high performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry (UHPLC/Q-TOF MS) was applied to identify the metabolites of honokiol in rat small intestines

  2015cites this paper
• Organ data from the developing Göttingen minipig: first steps towards a juvenile PBPK model

  2015cites this paper
• Dealing with the complex drug-drug interactions: towards mechanistic models.

  2015cites this paper
• Influence of non-steroidal anti-inflammatory drugs on intestinal permeability and non alcoholic fatty liver disease

  2015influential citation
• Drug Metabolism, Transport, and Pharmacogenomics

  2015cites this paper
• Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir

  2015cites this paper
• Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes.

  2015cites this paper
• COMPARISON OF ACTIVITIES OF GLUTATHIONE ENZYMES IN CEACUM AND LIVER OF CATTLE, HORSE, PIG, RABBIT AND SHEEP

  2015cites this paper
• Translational Concept and Determination of Drug Absorption

  2015cites this paper